U.S. Equities: I Want To Put All My Eggs In This Basket

Analyst rates U.S. equities a 'cautious buy', arguing that long‑term compounding potential driven by innovation, robust institutions and favorable demographics outweighs near‑term valuation concerns. He recommends core exposure via broad ETFs such as QQQ and SPY to hedge company‑specific risk, is selectively increasing U.S. exposure while accumulating cash, and discloses beneficial long positions in NVDA, GOOGL and AMZN.

Analysis

Market structure: The vote-for-U.S. thesis concentrates flows into mega-cap tech (NVDA, GOOGL, AMZN) and passive vehicles (QQQ/SPY), boosting pricing power for platform/cloud and AI-accelerator suppliers while squeezing small-cap, EM equities and commodity exporters. Tight GPU/AI component supply implies seller pricing power for ~6–12 months until fabs expand; expect concentrated index leadership to increase correlation and lower idiosyncratic alpha in the near term.

Risk assessment: Tail risks include an antitrust/regulatory shock (major DOJ/FTC action within 6–12 months), a GPU supply-chain failure, or a faster Fed hiking cycle that could trigger a 20–40% rerating in growth tech. Immediate (days) risks are options-driven gamma and earnings; short-term (3–6 months) is flows/positioning; long-term (3–5 years) remains structural growth but with concentration and capex-cycle dependence.

Trade implications: Core allocation to QQQ/SPY is sensible for long-run compounding but should be paired with concentrated growth positions: NVDA as the primary growth lever, GOOGL/AMZN as scale/advertising/cloud exposure. Use pairs (long QQQ, short EEM) to express U.S. vs EM, buy limited-risk options (3-month NVDA 5% OTM calls sized to 0.5–1% portfolio risk) and trim on 20–30% rallies or if index concentration metrics exceed thresholds.

Contrarian angles: Consensus underestimates concentration and regulatory second-order effects — if top-5 QQQ weight >35% or NVDA forward P/E >60, vulnerability to >25% drawdowns rises. Historical parallels to late-90s show outcomes diverge when earnings are real; here the surprise risk is supply-driven margin compression once capex cycles flood the market, so size positions with explicit stop/hedge rules.

Key Decisions for Investors

• Establish a 8–12% core allocation to QQQ or a 60/40 split of QQQ/SPY over 2–6 weeks, funded by trimming EM equities (reduce EEM exposure by ~50%) to express U.S. outperformance over 3–12 months.
• Add a 2–3% long position in NVDA (ticker NVDA) as a targeted growth holding and size a protective options sleeve: buy 3-month calls 5% OTM sized to 0.5–1.0% portfolio risk; trim half the NVDA position if the shares rally >20% within 30 days or NVDA forward P/E exceeds 60.
• Establish a relative-value pair: long QQQ equal-notional short EEM (emerging-market ETF) for a 3–6 month tactical trade to capture U.S. vs EM flow differential; rebalance monthly and exit if USD index weakens >3% or MSCI EM outperforms MSCI World by >5% over 30 days.
• Deploy a downside hedge: buy 3-month QQQ puts ~2% OTM sized to protect 20% of tech exposure (cost target <0.25% portfolio); increase hedges if 10-year Treasury yield rises >50 bps in 30 days or VIX spikes >25.
• Reduce cyclical/small-cap beta by 30–50% and rotate proceeds into cloud/AI names (GOOGL 1–2%, AMZN 1%) over 4–8 weeks; exit or re-evaluate if regulatory actions are filed within 6–12 months or if top-5 QQQ weight exceeds 35%.